Peter Nigrovic, MD

Chief, Division of Immunology; Rheumatologist, Rheumatology Program

Professor of Pediatrics, Harvard Medical School

Phone 617-355-6117

Fax 617-730-0249

NPI 1154388528

Print Profile

Request an Appointment

View Research Profile

Locations

Listen

Peter Nigrovic, MD

Chief, Division of Immunology; Rheumatologist, Rheumatology Program

Professor of Pediatrics, Harvard Medical School

Medical Services

Languages

English

Spanish

Education

Undergraduate School

Amherst College

1989

Amherst

Medical School

Harvard Medical School

Boston

Internship

Massachusetts General Hospital

1996

Boston

Residency

Massachusetts General Hospital

1999

Boston

Fellowship

Brigham & Women's Hospital

2004

Boston

Fellowship

Boston Children's Hospital

2006

Boston

Certifications

American Board of Pediatrics (Rheumatology)

American Board of Internal Medicine (Adult Rheumatology)

Professional History

Dr. Nigrovic graduated from Amherst College in philosophy and obtained his medical doctorate at Harvard Medical School. He trained in pediatrics and internal medicine at the Harvard Combined Med/Peds Program before completing fellowship in pediatric and adult rheumatology at Boston Children’s Hospital and the Brigham and Women’s Hospital, joining the staff of both hospitals in 2004. In 2021 he became Chief of the Division of Immunology at Boston Children’s Hospital. He also directs the Brigham’s Center for Adults with Pediatric Rheumatic Illness (CAPRI), specializing in the long-term care of individuals with childhood-onset rheumatic disease. In his academic work, he directs the Nigrovic laboratory, a basic and translational research group focused on mechanisms of inflammation in arthritis and systemic lupus erythematosus. He is Professor of Pediatrics and holds the Prince Turki Bin Abdul Aziz Al-Saud Chair in Pediatrics at Harvard Medical School, and is an elected member of the American Society for Clinical Investigation.

Publications

Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. View Abstract

Utility of Cytokine Biomarkers for the Diagnosis of Pediatric Pyogenic Musculoskeletal Infections. View Abstract

The joint accumulation model of arthritis. View Abstract

Early transcriptional effects of inflammatory cytokines reveal highly redundant cytokine networks. View Abstract

A GPVI-platelet-neutrophil-NET axis drives systemic sclerosis. View Abstract

Macrophage Activation Syndrome. View Abstract

The 'Treg paradox' in inflammatory arthritis. View Abstract

Features of hyperinflammation link the biology of Epstein-Barr virus infection and cytokine storm syndromes. View Abstract

Sex-specific NLRP3 activation in neutrophils promotes neutrophil recruitment and NETosis in the murine model of diffuse alveolar hemorrhage. View Abstract

EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease. View Abstract

Functional genomics implicates natural killer cells in the pathogenesis of ankylosing spondylitis. View Abstract

Regional specialization within the mammalian respiratory immune system. View Abstract

Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis. View Abstract

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus. View Abstract

Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus. View Abstract

Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework. View Abstract

Functional genomics implicates natural killer cells in the pathogenesis of ankylosing spondylitis. View Abstract

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus. View Abstract

Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis. View Abstract

"Rounding Third Base and Heading Home": Arthritis & Rheumatology in 2024. View Abstract

Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development. View Abstract

Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant. View Abstract

Recent advances and evolving concepts in Still's disease. View Abstract

The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease. View Abstract

Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework. View Abstract

Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts. View Abstract

Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. View Abstract

Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. View Abstract

Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant. View Abstract

Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. View Abstract

NLRP3 is essential for neutrophil polarization and chemotaxis in response to leukotriene B4 gradient. View Abstract

Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design. View Abstract

Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. View Abstract

Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2. View Abstract

Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children. View Abstract

Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. View Abstract

First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. View Abstract

mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome. View Abstract

Joint-Specific Memory and Sustained Risk for New Joint Accumulation in Autoimmune Arthritis. View Abstract

VEXAS Syndrome and Disease Taxonomy in Rheumatology. View Abstract

TET2-mutant clonal hematopoiesis and risk of gout. View Abstract

Correction: Stoll et al. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. Children 2022, 9, 569. View Abstract

An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract

The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis. View Abstract

Arthritis & Rheumatology: "Mid-Term" Report. View Abstract

Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. View Abstract

Neutrophil transit time and localization within the megakaryocyte define morphologically distinct forms of emperipolesis. View Abstract

Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis. View Abstract

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. View Abstract

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. View Abstract

Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. View Abstract

Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis. View Abstract

Weekly Adalimumab, an Effective Alternative for Refractory Uveitis in Children. View Abstract

Arthritis flares mediated by tissue-resident memory T cells in the joint. View Abstract

Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. View Abstract

IL-1ß-driven osteoclastogenic Tregs accelerate bone erosion in arthritis. View Abstract

Serologic Response to Borrelia Antigens Varies with Clinical Phenotype in Children and Young Adults with Lyme Disease. View Abstract

Genome editing to define the function of risk loci and variants in rheumatic disease. View Abstract

A multidisciplinary assessment of pain in juvenile idiopathic arthritis. View Abstract

Effects of Estradiol on Immunoglobulin G Glycosylation: Mapping of the Downstream Signaling Mechanism. View Abstract

Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation. View Abstract

The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments. View Abstract

Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. View Abstract

Publisher Correction: Biological classification of childhood arthritis: roadmap to a molecular nomenclature. View Abstract

A Picture Is Worth a Thousand Words, But Only If It Is a Good Picture. View Abstract

Biological classification of childhood arthritis: roadmap to a molecular nomenclature. View Abstract

Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity. View Abstract

Estrogen-Driven Changes in Immunoglobulin G Fc Glycosylation. View Abstract

Intraperitoneal corticosteroids for recurrent ascites in patients with Fontan circulation: Initial clinical experience. View Abstract

COVID-19 cytokine storm: what is in a name? View Abstract

Reply. View Abstract

Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. View Abstract

Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. View Abstract

Effects of estradiol on biological age measured using the glycan age index. View Abstract

The "Infodemic" of COVID-19. View Abstract

NF-E2-Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus. View Abstract

Arthritis & Rheumatology: Evolving to Meet the Challenges of Rheumatology. View Abstract

The Fyn-Stat5 cascade is required for Fc? receptor-mediated mast cell function. View Abstract

Identification of Prevotella Oralis as a possible target antigen in children with Enthesitis related arthritis. View Abstract

On the Alert for Cytokine Storm: Immunopathology in COVID-19. View Abstract

Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart. View Abstract

Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. View Abstract

Two- and three-color STORM analysis reveals higher-order assembly of leukotriene synthetic complexes on the nuclear envelope of murine neutrophils. View Abstract

Response to: 'Total adenosine deaminase highly correlated with adenosine deaminase 2 activity in serum' by Gao et al. View Abstract

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). View Abstract

Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon. View Abstract

Megakaryocyte emperipolesis: a new frontier in cell-in-cell interaction. View Abstract

Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. View Abstract

IgG Fc glycosylation as an axis of humoral immunity in childhood. View Abstract

PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. View Abstract

SerpinB1 controls encephalitogenic T helper cells in neuroinflammation. View Abstract

Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis. View Abstract

Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification. View Abstract

Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians. View Abstract

High-dimensional analysis reveals a pathogenic role of inflammatory monocytes in experimental diffuse alveolar hemorrhage. View Abstract

Increased ILC3s associated with higher levels of IL-1ß aggravates inflammatory arthritis in mice lacking phagocytic NADPH oxidase. View Abstract

A role for G protein-coupled receptor 137b in bone remodeling in mouse and zebrafish. View Abstract

ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-?B via phosphoinosotide remodeling of endosomes. View Abstract

Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. View Abstract

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. View Abstract

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. View Abstract

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. View Abstract

Antibody-dependent and -independent mechanisms of inflammatory arthritis. View Abstract

Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease. View Abstract

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. View Abstract

Differential attenuation of ß2 integrin-dependent and -independent neutrophil migration by Ly6G ligation. View Abstract

The organization of leukotriene biosynthesis on the nuclear envelope revealed by single molecule localization microscopy and computational analyses. View Abstract

Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone? View Abstract

Megakaryocytes as immune cells. View Abstract

Maestro endothelium conducts the neutrophils. View Abstract

Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes. View Abstract

High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. View Abstract

Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis. View Abstract

Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. View Abstract

Hip Synovial Fluid Cell Counts in Children From a Lyme Disease Endemic Area. View Abstract

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases. View Abstract

Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST). View Abstract

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. View Abstract

Barriers and Facilitators of Mentoring for Trainees and Early Career Investigators in Rheumatology Research: Current State, Identification of Needs, and Road Map to an Inter-Institutional Adult Rheumatology Mentoring Program. View Abstract

Age and fecal microbial strain-specific differences in patients with spondyloarthritis. View Abstract

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis. View Abstract

Mycobacterial infection induces higher interleukin-1ß and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase. View Abstract

High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis. View Abstract

Review: Genetics and the Classification of Arthritis in Adults and Children. View Abstract

Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci. View Abstract

Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate. View Abstract

CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation. View Abstract

The metabolic regulator mTORC1 controls terminal myeloid differentiation. View Abstract

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans. View Abstract

Megakaryocytes compensate for Kit insufficiency in murine arthritis. View Abstract

Building an ARC to Grant Success: The Aims Review Committee. View Abstract

Estrogens regulate glycosylation of IgG in women and men. View Abstract

Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. View Abstract

Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. View Abstract

Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. View Abstract

Frequency and Morbidity of Temporomandibular Joint Involvement in Adult Patients With a History of Juvenile Idiopathic Arthritis. View Abstract

Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis. View Abstract

Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses. View Abstract

The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1. View Abstract

Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. View Abstract

Efficacy of an Interinstitutional Mentoring Program Within Pediatric Rheumatology. View Abstract

Editorial: 21st Century Storm Chasers: Defining Macrophage Activation Syndrome. View Abstract

Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis. View Abstract

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis. View Abstract

Increased pretreatment serum IFN-ß/a ratio predicts non-response to tumour necrosis factor a inhibition in rheumatoid arthritis. View Abstract

MICL controls inflammation in rheumatoid arthritis. View Abstract

Redox Regulation of Pro-IL-1ß Processing May Contribute to the Increased Severity of Serum-Induced Arthritis in NOX2-Deficient Mice. View Abstract

Inhibition of inflammatory arthritis using fullerene nanomaterials. View Abstract

Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity. View Abstract

Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. View Abstract

Evaluation of synovial mast cell functions in autoimmune arthritis. View Abstract

Reply: To PMID 24623686. View Abstract

Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al. View Abstract

Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. View Abstract

Highly parallel characterization of IgG Fc binding interactions. View Abstract

IL-33/ST2 axis promotes mast cell survival via BCLXL. View Abstract

Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? View Abstract

Choosing Wisely: the American College of Rheumatology's Top 5 for pediatric rheumatology. View Abstract

A119: deep sequencing analysis of the T regulatory and T effector repertoire in juvenile idiopathic arthritis. View Abstract

A161: Novel 3-Dimensional Explant Method Facilitates the Study of Lymphocyte Populations in the Synovium and Reveals a Large Population of Resident Memory T cells in Rheumatoid Arthritis. View Abstract

A177: Program Evaluation of the ACR/CARRA Inter-Institutional Mentoring Program (AMIGO) in Pediatric Rheumatology. View Abstract

AMIGO: a novel approach to the mentorship gap in pediatric rheumatology. View Abstract

Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. View Abstract

Synovial fluid findings in children with knee monoarthritis in lyme disease endemic areas. View Abstract

Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. View Abstract

Dr. Henderson, et al reply. View Abstract

Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. View Abstract

Sweets are good for you: fine tuning antibodies via glycosylation. View Abstract

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. View Abstract

Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. View Abstract

Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. View Abstract

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. View Abstract

Ly6 family proteins in neutrophil biology. View Abstract

PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis. View Abstract

Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies. View Abstract

Ly6G: a work in progress--author's reply to Yipp. View Abstract

The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. View Abstract

Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis. View Abstract

Interleukin-33 primes mast cells for activation by IgG immune complexes. View Abstract

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. View Abstract

Platelets: active players in the pathogenesis of arthritis and SLE. View Abstract

Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. View Abstract

Ly6G ligation blocks recruitment of neutrophils via a ß2-integrin-dependent mechanism. View Abstract

Platelets can enhance vascular permeability. View Abstract

Ras guanine nucleotide-releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis. View Abstract

Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. View Abstract

Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis. View Abstract

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. View Abstract

C5a receptor enables participation of mast cells in immune complex arthritis independently of Fc? receptor modulation. View Abstract

Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1). View Abstract

Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. View Abstract

Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. View Abstract

Juvenile psoriatic arthritis: bathwater or baby? View Abstract

Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. View Abstract

Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. View Abstract

Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. View Abstract

Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. View Abstract

Overview of hip pain in childhood View Abstract

Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS) View Abstract

Evaluation of the child with back pain View Abstract

Overview of the causes of back pain in children and adolescents View Abstract

Mast cells View Abstract

Periodic fever syndromes and other autoinflammatory diseases: An overview View Abstract

Hemarthrosis View Abstract

Mast cells View Abstract

Mast cells contribute to autoimmune inflammatory arthritis via tryptase•heparin complexes View Abstract

Laboratory and imaging studies in rheumatology View Abstract

Synovial mast cells: role in acute and chronic arthritis. View Abstract

Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. View Abstract

Mast cells in acute and chronic inflammatory arthritis View Abstract

Patients with juvenile psoriatic arthritis comprise two distinct populations. View Abstract

Subpopulations within juvenile psoriatic arthritis: a review of the literature. View Abstract

Extreme thrombocytosis predicts Kawasaki disease in infants. View Abstract

Care of the adult with juvenile rheumatoid arthritis. View Abstract

Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. View Abstract

Particularities of the vasculature can promote the organ specificity of autoimmune attack. View Abstract

Innate immunity and immune complexes in rheumatoid arthritis View Abstract

Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. View Abstract

Mast cells in autoantibody responses and arthritis. View Abstract

Anti-inflammatory and immunomodulatory therapy View Abstract

Mast cells in inflammatory arthritis. View Abstract

Raynaud's phenomenon in children: a retrospective review of 123 patients. View Abstract

Spanish for Pediatric Medicine View Abstract

Kawasaki syndrome and acquired heart disease View Abstract

Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. View Abstract

Treatment of TRAPS with etanercept: use in pediatrics. View Abstract

Treatment of allergic asthma with monoclonal anti-IgE antibody View Abstract

Tuberculosis in Los Lomas Zaragoza, Chimaltenango View Abstract

Locations